Mesenchymal stromal cell migration: possibilities to improve cellular therapy

Area of Science:

• Stem cell biology
• Regenerative medicine
• Immunology

Background:

• Mesenchymal stromal cells (MSCs) are multipotent cells with regenerative and immune modulatory properties, offering promise for clinical applications.
• Numerous clinical trials are investigating MSCs for treating various diseases.
• Current MSC expansion protocols require extensive culture periods (3-6 weeks) to generate sufficient cell numbers for transplantation.

Purpose of the Study:

• To review the current understanding of Mesenchymal stromal cell (MSC) migration.
• To explore how MSC expansion protocols affect their homing capacity.
• To identify strategies for improving MSC-based therapies by maintaining migration and homing capabilities.

Main Methods:

• Literature review focusing on Mesenchymal stromal cell (MSC) migration studies.
• Analysis of factors influencing MSC homing and engraftment.
• Discussion of potential modifications to MSC expansion protocols.

Main Results:

• Extensive ex vivo expansion significantly diminishes the engraftment potential of Mesenchymal stromal cells (MSCs).
• MSC expansion cultures often start with heterogeneous, undefined cell populations, complicating the understanding of which cells are expanded.
• The loss of homing capacity in expanded MSCs is a critical barrier to their therapeutic efficacy.

Conclusions:

• Optimizing Mesenchymal stromal cell (MSC) expansion protocols is crucial for preserving their migration and homing abilities.
• Further research into MSC migration mechanisms can guide the development of more effective cell-based therapies.
• Improving MSC homing capacity post-expansion is essential for successful clinical translation.